Kolexia
Pouplard Claire Pharmacien
Pouplard Claire
Pharmacien
Hôpital Trousseau Chambray lès Tours
Chambray-lès-Tours, France
128 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Thrombopénie Hémophilie A Thrombose Microangiopathies thrombotiques Prédisposition génétique à une maladie Syndrome des anticorps antiphospholipides Maladies de von Willebrand Hypertension artérielle Défaillance cardiaque

Collaborateurs

Voir plus
Gruel Yves
Gruel Yves
CHU Tours, Tours, France
Vayne Caroline
Vayne Caroline
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France
Ternisien Catherine
Ternisien Catherine
Hôpital Hôtel-Dieu Nantes, Nantes, France
Jeanpierre-Tomolillo Emmanuelle
Jeanpierre-Tomolillo Emmanuelle
Hôpital Albert Calmette, Lille, France

Industries

Voir plus
Sobi
14 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2023
Bayer
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study.
Thrombosis research   20 juillet 2023
Hémophilie
HAS Publications   20 juin 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology.
Journal of thrombosis and haemostasis : JTH   16 juin 2023
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis.
Thrombosis and haemostasis   09 février 2023
PO102 A FRENCH REAL-WORLD EVIDENCE STUDY EVALUATING THE EFFICACY, SAFETY AND PHARMACOKINETIC PARAMETERS OF RVIII-SINGLECHAIN IN PATIENTS WITH HEMOPHILIA A RECEIVING PROPHYLAXIS
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
Results of samples spiked with chimeric monoclonal anti-PF4 antibody 1C12 in ECAT external quality assessment surveys for heparin-induced thrombocytopenia diagnosis
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Cooperation between PF4-specific antibodies in heparin-induced thrombocytopenia: A new mechanism potentially contributing to hypercoagulability and thrombosis
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
Contribution of biology to the diagnosis and follow-up of VITT: A French multicentre experience
Abstracts of the ISTH 2022 Congress of the International Society of Thrombosis and Haemostasis, July 9–13, 2022   21 octobre 2022
The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies.
Haematologica   01 octobre 2022
Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
Journal of thrombosis and haemostasis : JTH   02 septembre 2022